Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 19.


Connor, AA, Denroche, RE, Jang, GH, Timms, L, Kalimuthu, SN, Selander, I, McPherson, T, Wilson, GW, Chan-Seng-Yue, MA, Borozan, I
et al (show 30 more authors) (2016) Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma. JAMA oncology, 3 (6). pp. 774-783.


Rizzato, C, Campa, D, Talar-Wojnarowska, R, Halloran, C ORCID: 0000-0002-5471-4178, Kupcinskas, J, Butturini, G, Mohelníková-Duchoňová, B, Sperti, C, Tjaden, C, Ghaneh, P
et al (show 19 more authors) (2016) Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients. Carcinogenesis, 37 (10). pp. 957-964.


Psarelli, EE ORCID: 0000-0002-3102-0288, Jackson, R, Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Ghaneh, P, Halloran, CM ORCID: 0000-0002-5471-4178 and Buechler, MW
(2017) Beyond ESPAC-4: better surgery and systemic therapy. LANCET, 389 (10078). pp. 1517-1518.


Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Ghaneh, P, Psarelli, EE ORCID: 0000-0002-3102-0288, Valle, JW, Halloran, CM ORCID: 0000-0002-5471-4178, Faluyi, O, O'Reilly, DA, Cunningham, D, Wadsley, J
et al (show 24 more authors) (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet (London, England), 389 (10073). pp. 1011-1024.


Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Ghaneh, P, Psarelli, EE ORCID: 0000-0002-3102-0288, Valle, JW, Halloran, CM ORCID: 0000-0002-5471-4178, Faluyi, O, O'Reilly, DA, Cunningham, D, Wadsley, J
et al (show 24 more authors) (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet (London, England), 389 (10073). 1011 - 1024.


Elander, NO, Aughton, K ORCID: 0000-0002-5184-5789, Ghaneh, P, Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Cox, TF, Campbell, F, Costello-Goldring, E ORCID: 0000-0002-0104-8992, Halloran, CM ORCID: 0000-0002-5471-4178, Mackey, JR
et al (show 16 more authors) (2018) Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predict survival in pancreatic cancer. British Journal of Cancer, 118 (7). pp. 947-954.


Martinelli, P, Pau, ECDS, Cox, T, Sainz, B, Dusetti, N, Greenhalf, W, Rinaldi, L, Costello, E, Ghaneh, P, Malats, N
et al (show 6 more authors) (2017) GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer. Gut, 66 (9). pp. 1665-1676.


Thomas, AJ
(2016) THE INVESTIGATION OF AT7519 (CDK INHIBITOR) AND AT13387 (HSP90 INHIBITOR) AS NOVEL THERAPIES FOR THE TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA. Doctor of Medicine thesis, University of Liverpool.


Sheel, ARG, Harrison, S, Sarantitis, I ORCID: 0000-0002-3905-1417, Nicholson, JA, Hanna, T, Grocock, C, Raraty, M, Ramesh, J, Farooq, A, Costello, E
et al (show 14 more authors) (2019) Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer. The American Journal of Gastroenterology (Elsevier), 114 (1). pp. 155-164.


Yafawi, A
(2018) Incidence of aneurysm growth following endovascular aneurysm sealing of abdominal aortic aneurysms and their associations with stent movement: retrospective observational study. Master of Philosophy thesis, University of Liverpool.


Elander, NO, Aughton, K ORCID: 0000-0002-5184-5789, Ghaneh, P, Neoptolemos, JP, Palmer, DH ORCID: 0000-0002-7147-5703, Cox, TF, Campbell, F, Costello, E, Halloran, CM ORCID: 0000-0002-5471-4178, Mackey, JR
et al (show 18 more authors) (2018) Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy. British Journal of Cancer, 118 (8). pp. 1084-1088.


Sheel, ARG, Baron, RD, Dickerson, LD ORCID: 0000-0001-6281-8658, Ghaneh, P, Campbell, F, Raraty, MGT, Yip, V, Halloran, CM ORCID: 0000-0002-5471-4178 and Neoptolemos, JP
(2019) The Liverpool duodenum-and spleen-preserving near-total pancreatectomy can provide long-term pain relief in patients with end-stage chronic pancreatitis. LANGENBECKS ARCHIVES OF SURGERY, 404 (7). pp. 831-840.


Melling, J
(2017) Mechanisms of gemcitabine resistance in pancreatic cancer. Doctor of Medicine thesis, University of Liverpool.


Williams, D, Gana, T, Sivapalan, L, Butler, O, Jackson, R, Perez-Mancera, P, Barrera-Briceno, L, Copple, I, Cox, T, Goldring, C
et al (show 7 more authors) (2017) Nrf2 in Pancreatic Cancer Chemotherapy Response and the Use of Brusatol as a Chemotherapeutic Agent. .


Gomatis, I, Halloran, CM ORCID: 0000-0002-5471-4178, Ghaneh, P, Raraty, M, Polydoros, F ORCID: 0000-0001-5181-6817, Evans, JC, Smart, HL, Yagati-Satchidanand, R, Garry, JM, Whelan, PA
et al (show 3 more authors) (2016) Outcomes From Minimal Access Retroperitoneal and Open Pancreatic Necrosectomy in 394 Patients With Necrotizing Pancreatitis. Annals of Surgery, 263 (5). pp. 992-1001.


Ghaneh, P, Wong, WL, Titman, A, Plumpton, C, Vinjamuri, S, Johnson, C, Abu Hilal, M, Higginson, A, Smith, AM, Scarsbrook, A
et al (show 10 more authors) (2016) PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer. In: American Society of Clinical Oncology, 2016-6-3 - 2016-6-7, Chicago.


Rao, R Gopala, Costello, E, Halloran, CM ORCID: 0000-0002-5471-4178, Oldfield, L ORCID: 0000-0002-0839-402X, Greenhalf, W, Ghaneh, P, Neoptolemos, JP, Purewal, T, Evans, A and Mann, K
(2017) The Prevalence of Diabetes Mellitus is Significantly Higher for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma Compared to Surgery for Other Pancreatic Pathologies. .


Mann, Kulbir, Gilbert, T, Cicconi, S ORCID: 0000-0001-5507-6203, Jackson, R, Whelan, P, Campbell, F, Halloran, C ORCID: 0000-0002-5471-4178, Neoptolemos, J and Ghaneh, P
(2019) Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma. LANGENBECKS ARCHIVES OF SURGERY, 404 (4). pp. 439-449.


Sultana, A, Jackson, R, Gilbert, Tim, Bostock, Emma, Psarelli, E ORCID: 0000-0002-3102-0288, Cox, T, Sutton, R ORCID: 0000-0001-6600-562X, Ghaneh, P, Raraty, M, Neoptolemos, J
et al (show 1 more authors) (2015) What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses. Clinical and Translational Gastroenterology, 6 (12). e130-e130.

This list was generated on Mon Mar 11 08:03:22 2024 GMT.